Fibroblast growth factors released by wounded endothelial cells stimulate proliferation of synovial cells.
We demonstrated that vascular endothelial cells mechanically wounded by scraping from the substratum were able to release growth promoting factors for synovial cells as well as for endothelial cells. The wounded endothelial cell conditioned medium stimulated the proliferation of synovial cells derived from different human donors dose dependently and induced transit of growth arrested synovial cells (predominant in the G0 and G1 phases), through the S phase and into the G2 and M phases. When the wounded endothelial cell conditioned medium was applied to heparin-sepharose columns, mitogenic activity was eluted with 2.0 M NaCl. The mitogenic activity in wounded endothelial cell conditioned medium, which was heat sensitive, was inhibited by protamine sulfate and a specific mouse monoclonal antibody against basic fibroblast growth factor (bFGF). Our results are evidence that the wounded endothelial cell conditioned medium contained growth promoting factors for synovial cells, including bFGF. We also showed the presence of bFGF in the endothelial cells of the small blood vessels and stromal synovial fibroblast-like cells in patients with rheumatoid arthritis (RA). Our results suggest that the endothelial cells in the luxuriant capillaries in the synovial tissues from patients with RA may have a critical role in the stimulation of neighboring synovial cell proliferation, resulting in pronounced synovial hyperplasia.
Eguchi
K
K
First Department of Internal Medicine, Nagasaki University School of Medicine, Japan.
Migita
K
K
Nakashima
M
M
Ida
H
H
Terada
K
K
Sakai
M
M
Kawakami
A
A
Aoyagi
T
T
Ishimaru
T
T
Nagataki
S
S
D000911:Antibodies, Monoclonal / Q000276:immunology / Q000494:pharmacology; D001172:Arthritis, Rheumatoid / Q000378:metabolism / Q000473:pathology; D002453:Cell Cycle; D002455:Cell Division / Q000187:drug effects / Q000502:physiology; D002478:Cells, Cultured; D002846:Chromatography, Affinity; D017077:Culture Media, Conditioned / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004730:Endothelium, Vascular / Q000166:cytology* / Q000293:injuries / Q000378:metabolism*; D016222:Fibroblast Growth Factor 2 / Q000276:immunology / Q000378:metabolism* / Q000502:physiology*; D005347:Fibroblasts / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D011479:Protamines / Q000494:pharmacology; D013583:Synovial Membrane / Q000293:injuries / Q000378:metabolism / Q000473:pathology*
D000911:Antibodies, Monoclonal; D017077:Culture Media, Conditioned; D011479:Protamines; D016222:Fibroblast Growth Factor 2